Skip to main content
Log in

Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effects of inhaled budesonide (BUD) and oral prednisolone (PRED) on markers of bone turnover and adrenal function were compared in a randomized, double-blind, double-dummy, crossover study. Twelve healthy subjects were treated for one week with 0.8, 1.6 and 3.2 mg/day BUD and 5, 10 and 20 mg/day PRED, the three doses being given in ascending order. Plasma cortisol and adrenal cortical androgens showed a significantly decreasing trend with the increasing doses of both drugs, although PRED caused a significantly greater decrease than BUD. Osteoblast function, reflected by serum osteocalcin and alkaline phosphatase was significantly reduced by PRED, but BUD had a significantly different effect as it affected only osteocalcin. Urinary hydroxyproline/creatinine, a marker of bone resorption, was not changed by either drug. The average potency ratio for equivalent systemic effects was PRED:BUD 3.9:1. During short-term treatment at equivalent anti-asthmatic doses, BUD has significantly less effect on adrenal function and bone turnover than PRED, and it may carry less risk of bone complications during long-term treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Seale JP, Compton MR (1986) Side-effects of corticosteroid agents. Med J Aust 144: 139–142

    Google Scholar 

  2. Greenberger PA, Hendrix RW, Patterson R, Chmiel JS (1982) Bone studies in patients on prolonged systemic corticosteroid therapy for asthma. Clin Allergy 12: 363–368

    Google Scholar 

  3. Adinoff AD, Hollister JR (1983) Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309: 265–268

    Google Scholar 

  4. Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH (1985) Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthr Rheum 28: 361–368

    Google Scholar 

  5. Johansson SÅ, Andersson KE, Brattsand R, Gruvstad E, Hedner P (1982) Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man. Eur J Respir Dis 63 [Suppl 122]: 74–82

    Google Scholar 

  6. Ryrfeldt Å, Andersson P, Edsbäcker S, Tönnesson M, Davies D, Pauwels R (1982) Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis 63 [Suppl 122]: 86–95

    Google Scholar 

  7. Toodgood JH, Baskerville J, Jennings B, Lefcoe NM, Johansson SÅ (1989) Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin Immunol 84: 688–700

    Google Scholar 

  8. Chen TL, Feldman D (1979) Glucocorticoid receptors and actions in subpopulations of cultured rat bone cells: Mechanism of dexamethasone potentiation of parathyroid hormone-stimulated cyclic AMP production. J Clin Invest 63: 650–758

    Google Scholar 

  9. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH (1979) Altered mineral metabolism in glucocorticoid-induced osteopenia: Effect of 25(OH)D administration. J Clin Invest 64: 655–665

    Google Scholar 

  10. Hahn YJ (1980) Drug-induced disorders of vitamin D and mineral metabolism. Clin Endocrinol Metab 9: 107–129

    Google Scholar 

  11. Price PA, Baukol SA (1980) 1,25-Dihydroxyvitamin D3 increases synthesis of vitamin K-dependent bone protein by osteosarcoma cells. J Bioll Chem 255: 11660–11663

    Google Scholar 

  12. Martin TJ, Raisz LG, Rodan G (1987) Calcium regulation and bone metabolism. In: Martin TJ, Raisz LG (eds) Clinical endocrinology of calcium metabolism. Marcel Dekker, New York

    Google Scholar 

  13. Beresford JN, Gallagher JA, Poser JW, Russell RGG (1984) Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, parathyroid hormone and glucocorticoids. Metab Bone Dis Rel Res 5: 229–234

    Google Scholar 

  14. Luckert BP, Higgins JC, Stoskopf MM (1986) Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab 62: 1056–1058

    Google Scholar 

  15. Ekenstam E, St»lenheim G, Hällgren R (1988) The acute effect of high dose corticosteroid treatment on serum osteocalcin. Metabolism 37: 141–144

    Google Scholar 

  16. Jasin HE, Fink CW, Wise W, Ziff M (1962) Relationship between urinary hydroxyproline and growth. J Clin Invest 41: 1928–1935

    Google Scholar 

  17. Dull TA, Henneman PH (1963) Urinary hydroxyproline as an index of collagen turnover in bone. N Engl J Med 268: 132–134

    Google Scholar 

  18. Smiley JD, Ziff M (1964) Urinary hydroxyproline excretion and growth. Physiol Rev 44: 30–44

    Google Scholar 

  19. Need AG, Hartley TF, Philcox JC, Nordin BEC (1986) Calcium metabolism and osteoporosis in corticosteroid-treated post-menopausal women. Aust NZ J Med 16: 341–346

    Google Scholar 

  20. Gennari C, Imbimbo B, Montagnani M, Bernini M, Nardi P, Avioli LV (1984) Effects of prednisolone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Int 36: 245–252

    Google Scholar 

  21. Reid IR (1989) Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 30: 83–103

    Google Scholar 

  22. Podenphant J, Larsen NE, Christiansen C (1984) An easy and reliable method for determination of urinary hydroxyproline. Clin Chim Acta 142: 145–148

    Google Scholar 

  23. Toogood JH, Baskerville JC, Jennings BH, Lefcoe NM, Johansson SÅ (1982) Influence of dosing frequency and schedule on response of chronic asthmatics to aerosol steroid, budesonide. J Allergy Clin Immunol 70: 288

    Google Scholar 

  24. Nordin BEC, Marshall DH, Francis RM, Crilly RG (1981) The effects of sex steroid and corticosteroid hormones on bone. J Steroid Biochem 15: 171–174

    Google Scholar 

  25. Price PA, Parthemore JG, Deftos LJ, Nishimoto SK (1980) New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone Gla protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 66: 878–883

    Google Scholar 

  26. Deftos LJ, Parthemore JG, Price PA (1982) Changes in plasma bone Gla protein during treatment of bone disease. Calcif Tissue Int 34: 121–124

    Google Scholar 

  27. Slovik DM, Gunberg CM, Neer RM, Lian JB (1984) Clinical evaluation of bone turnover by serum osteocalcium measurements in a hospital setting. J Clin Endocrinol Metab 59: 228–230

    Google Scholar 

  28. Kruse K, Kracht U (1986) Evaluation of serum osteocalcin as an index of altered bone metabolism. Eur J Paediatr 145: 27–33

    Google Scholar 

  29. De La Piedra C, Toural V, Rapado A (1987) Osteocalcin and urinary hydroxyproline/creatinine ratio in the differential diagnosis of primary hyperparathyroidism and hypercalcaemia of malignancy. Scand J Clin Lab Inv 47: 587–592

    Google Scholar 

  30. Jowsey J, Riggs BL (1970) Bone formation in hypercortisolism. Acta Endocrinol 63: 21–28

    Google Scholar 

  31. Crilly RG, Marshall DH, Nordin BEC (1979) Metabolic effects of corticosteroid therapy in post-menopausal women. J Steroid Biochem 11: 429–433

    Google Scholar 

  32. Cascia V, Bonucci E, Imbimbo B, Ballanti P, Tartarotti D, Galvanini G, Fuccella L, Adimi S (1984) Bone loss after glucocorticoid therapy. Calcif Tissue Int 36: 435–438

    Google Scholar 

  33. Ali NJ, Capewell S, Ward MJ (1989) Bone turnover during high dose inhaled corticosteroid therapy. Thorax 44: 900P

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jennings, B.H., Andersson, K.E. & Johansson, S. Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol 40, 77–82 (1991). https://doi.org/10.1007/BF00315143

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00315143

Key words

Navigation